Discussion
In this study, we used a suite of modelling approaches to (1) characterise correlates for reported RSV infections, (2) quantify age structure in the force of RSV infection, (3) document seasonality in RSV transmission and (4) identify possible climatic drivers of this seasonality in the low-income setting of Antananarivo, Madagascar.
The results of our analysis of correlates of RSV transmission are consistent with those previously documented for this disease, both in Madagascar and elsewhere7 9 58: we find that reported hospitalisations for RSV are largely concentrated in very young patients (≤2 years of age) with a potential weaker association in elderly individuals (>60 years of age). Our quantification of the age-structured FOI for RSV indicates that the most intense transmission is focused on infants aged less than 1 year, with transmission intensity steadily decreasing to near-zero after 4 years of age, before rising again in elderly cohorts. Because we fit our FOI models to reported cases only, it is possible that less pathogenic RSV transmission may dominate among older children, resulting in asymptomatic infections, as has been previously suggested in the analysis of age-structured serological data from other regions.59 Our crude estimates for RSV R0, which we computed from the average age of infection and mean population-level birth rate, as well as from the mean susceptible population estimated from TSIR, additionally suggest that RSV transmission is elevated in Antananarivo, as compared with global averages.53–57 Again, our reliance on reported cases likely upwardly biases these calculations by over-representing more pathogenic strains or more vulnerable populations or both. Nonetheless, these estimates fall well within reported ranges for RSV R0,53–57 and a slightly elevated RSV transmission rate is not illogical, given Antananarivo’s young and densely aggregated population.
In addition to describing the magnitude and age structure of RSV transmission, our study also successfully quantifies intra-annual seasonality in RSV dynamics in Antananarivo. A seasonal concentration of RSV burden in the first half of the calendar year in Madagascar has been previously suggested based on more qualitative examination of the raw case data8 9; however, our study is the first to actually quantify RSV transmission, which slightly precedes cases. Our investigation of climatic correlates of the weekly transmission rate echoes recent work from the Northern Hemisphere which highlights a significant positive role for precipitation and negative role for humidity in driving RSV transmission dynamics.17 In addition, we identify a significant (though weaker) positive correlation between RSV transmission and temperature in Antananarivo. Because high temperatures and high precipitation are themselves correlated in tropical Madagascar’s rainy season, which spans October to March, it is possible that this muted contribution of temperature to RSV transmission dynamics may simply be an artefact of the precipitation driver, rather than a causative association of its own.
Our examination of interannual trends in the climate data suggests that precipitation, humidity and temperature have all increased across the past decade study period in Antananarivo, but that average RSV case load has remained constant. As high precipitation is associated with elevated RSV transmission rates, but high humidity is associated with lower RSV transmission rates in our dataset, it is possible that these climate drivers have had largely neutralising effects on the overall RSV burden throughout our time series. Nonetheless, our statistical models demonstrate a more pronounced effect of precipitation on the overall variation in observed RSV transmission, as has been reported in other tropical locations that demonstrate high average annual humidity with minimal variation across the year.17 Though there is no animal model available to empirically test the effects of climate on RSV transmission, experimental work in influenza has demonstrated that low humidity conditions favour transmission between guinea pigs, as a result of either increased survival of the virus and/or extended duration of virus circulation in aerosols under drier conditions.60 By contrast, though a population-level influence of precipitation has been observed on both influenza60–62 and RSV18 63 transmission, this effect has never been tested experimentally. Future studies empirically elucidating the mechanisms that underlie climate impacts on respiratory virus transmission would do much to validate our results. Future climate impacts on RSV transmission are likely to depend on the relative slope of each climate driver’s projected increase in a specific locality: over the past decade, precipitation has increased at a faster rate than humidity in tropical Antananarivo. If current trends hold, higher precipitation could drive future RSV transmission beyond the tempering effects of humidity.
Finally, our analysis highlights a few years in our decade-long time series that vary significantly from the overall trend, with higher-than-average or lower-than-average RSV-attributed infections and, in 1 year (2012), an irregular, off-season peak. Prior work in other systems has described off-season RSV epidemics attributed to irregular climate patterns,64 but we were unable to identify any association between deviant years in the RSV time series in Antananarivo and any observed climatic anomalies. Higher-than-average or lower-than average RSV burden in a given year could instead reflect the complex interplay between host immunity and circulating viral genotypes—both those of RSV itself, for which two major subtypes are known,65 and those of other respiratory infections known to induce some degree of anti-RSV cross-protective immunity.66 Prior sequencing efforts of Antananarivo RSV cases over the same time period indicate that year 2012 witnessed a transition in case load from the previously dominant RSV subtype B to RSV subtype A—genotype NA1, which was subsequently replaced by the introduction of the novel RSV subtype A—genotype ON1 in 2014.62 67 It is possible that the irregular seasonality of the RSV epidemic of 2012 reflects a lack of prior immunity in the Antananarivo CU5 population to RSV subtype B prior to turnover—though this hypothesis is impossible to test in the absence of additional viral genomic sequencing and paired subtype-specific serology. Off-season RSV transmission was well documented globally in 2020 and 2021 following relaxation of non-pharmaceutical interventions (NPIs) implemented to counter the initial spread of SARS-CoV-2.68 Intriguingly, our analysis did not recover any signature of aberrant RSV transmission for the year 2020 or 2021 in Antananarivo, suggesting that NPIs were largely unsuccessful at reducing respiratory virus transmission in this region during this time.9 Indeed, broad-scale serosurveys in 2020 and 2021 suggest that over 40% of the Antananarivo population was exposed to SARS-CoV-2 within the first 6 months of the pandemic,69 underscoring the relative ineffectiveness of NPIs on reducing respiratory disease burden.
Our study has several limitations. Our data were restricted to only a few reporting sites in Antananarivo, with most samples received from one sentinel site (CENHOSOA). This restricted geography somewhat impedes our ability to draw conclusions about broad trends in RSV dynamics across Madagascar. Additionally, as Madagascar is an isolated island in the Southwest Indian Ocean, understanding the drivers of RSV transmission in this locality may have limited potential for generalisability across the greater tropics. Influenza, for example, exhibits erratic seasonal dynamics in Madagascar that do not follow globally recognised patterns,70 limiting the extent to which transmission insights from Madagascar can be leveraged to guide policy interventions or surveillance elsewhere. Another limitation of our study is the necessarily arbitrary segregation of the population into discrete age classes for FOI estimation. While we attempted to consider all plausibly relevant delineations of age with respect to transmission, it is possible that we may have overlooked important dynamics hidden in untested hypotheses. Additionally, as mentioned, our dataset was limited to reported RSV cases only. More widespread prospective sampling of less virulent disease manifestations—either through molecular testing, or more feasibly, serology—would greatly enhance our inference into RSV transmission. Lastly, investigation of genome sequences would enable us to test hypotheses about the impact of virus genotype diversity on asynchronous and off-season dynamics.
In addition to challenges related to our own data and corresponding inference, we also faced challenges in the use of publicly available data for population sizes, birth rates and climate. In particular, we used government-reported values for the population served in the catchment area of each sentinel site in our analysis.28 29 Any uncertainty in these estimates could subsequently undermine downstream estimation of local birth rates and corresponding susceptible population reconstruction for input into TSIR. As a frequent limitation of TSIR approaches, we were additionally forced to extrapolate weekly birth rate data for our study population using very broad national-level, annual birth rate estimates from the World Bank. As seasonality in human birth rates has been shown to impact disease dynamics in other systems,71 lack of consideration of this effect in our analysis may somewhat undermine our inference into the transmission seasonality of RSV. More fine-scale birth data specifically tailored to our study region would do much to improve inference into infection dynamics. Finally, our climate records, which draw from Antananarivo at large, are (like our birth rate data) broad considering the highly localised (eg, within household) nature of the majority of RSV transmission.72 73 Despite these challenges, our modelling efforts recover plausible estimates for both the seasonality and R0 of reported cases of RSV in Antananarivo, suggesting that these uncertainties did not seriously impact our results.
All told, our study underscores the heavy morbidity and mortality burden that RSV presents to young children in Antananarivo and highlights an important role for climate in driving seasonal epidemics. Future changes in climatic parameters, particularly precipitation, are likely to impact RSV dynamics and may impact transmission, at least in the short term, in Madagascar. Introductions of new intervention strategies are greatly needed to mitigate RSV’s heavy mortality burden in low- and middle-income countries (LMICs)—especially considering possible intensification of burden in response to climate. RSV vaccines for older patients and pregnant mothers, as well as monoclonal antibody treatment for neonates, have recently become available in high-income countries.74 Despite projections of positive impact,75 these interventions have not yet reached the Global South, largely as a result of high cost barriers and lack of awareness of regional health authorities and communities regarding the burden of RSV. Shortages of human, financial and material resources, which jeopardise the provisioning of quality health services, are still a serious challenge in LMICs. As the majority of respiratory virus research is concentrated in the Global North, available interventions may additionally have limited efficacy in the Global South. In Madagascar, influenza vaccination is not included in the expanded programme on immunisation, and even if available, vaccine recommendations for both Northern and Southern Hemispheres are projected to be largely ineffective for Madagascar-specific influenza strains.76 Expansion of research into the dynamics and drivers of respiratory virus circulation in LMICs is thus greatly needed to inform the design of relevant therapeutics and guide the most effective plan for their introduction. Moreover, given that vaccines are not widely accessible and affordable for the whole population, efforts should be concentrated for vulnerable populations and resources allocated accordingly. Equitable global distribution of both infectious disease research and corresponding interventions need to be a major public health priority for the next decade.